Biotechnology Analysis & Statistics in the United States, February 2015

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

1-30 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

U.S. Orthopedic Biomaterials Market

U.S. Orthopedic Biomaterials Market

  • $ 6 995
  • Industry report
  • January 2015
  • by iData Research, Inc.

The fastest growing segments involve stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential ...

  • Industries : Biomaterial
  • Countries : United States
Global Markets for Implantable Biomaterials

Global Markets for Implantable Biomaterials

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

This BCC Research report examines the global market for medical biomaterials by geographic region and by market segment, and also provides an in-depth discussion and analysis of the application of biomaterials ...

  • Industries : Biomaterial
  • Countries : World, United States
US Biocompatible Materials Market

US Biocompatible Materials Market

  • $ 5 200
  • Industry report
  • December 2014
  • by Freedonia

US demand to grow 5.4% annually through 2018 US demand for biocompatible materials is forecast to grow 5.4 percent annually to $5.5 billion in 2018, representing 2.0 billion pounds. Reflecting quality, ...

  • Industries : Biomaterial
  • Countries : United States
Profiling of Select Biotech Markets in Asia - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

Profiling of Select Biotech Markets in Asia - 2015 ; Market size, Market trends, Growth drivers, Future forecast, Market opportunity

  • $ 2 500
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Profiling of select Biotech current market scenario, structure and practices in Asia. In depth profile scenario includes; - Key Biotech segments - Medical biotech, ...

  • Industries : Biotechnology
  • Countries : South Korea, Philippines, Asia, Taiwan, Malaysia, World, China, United States
Articular Cartilage Defect - Pipeline Review, H2 2014

Articular Cartilage Defect - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Articular Cartilage Defect - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Articular Cartilage Defect - Pipeline Review, H2 2014', provides an overview of the Articular Cartilage Defect's ...

  • Industries : Biological Therapy
  • Countries : World, United States
Oral Proteins and Peptides Market (2nd edition), 2015 - 2025

Oral Proteins and Peptides Market (2nd edition), 2015 - 2025

  • $ 1 899
  • Industry report
  • January 2015
  • by Roots Analysis Private Ltd.

The “Oral Proteins and Peptides Market (2nd edition), 2015-2025” report provides a comprehensive analysis of the current state of the market and the likely future evolution over the next ten years. ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biosimilars Business Review Q4 2014

Biosimilars Business Review Q4 2014

  • $ 1 114
  • Industry report
  • December 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - US Biosimilar Market Edged Closer In 2014, Intensifying Key Debates Industry Brief - Epirus Enters China Collaboration With Livzon Industry Trend Analysis - Amgen's Biosimila ...

  • Industries : Biopharmaceutical
  • Countries : India, China, United States, World
11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

  • $ 895
  • Industry report
  • December 2014
  • by BioPlan Associates, Inc.

The 2014 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current ...

  • Industries : Biopharmaceutical
  • Countries : United States, Europe, World
Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Calypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis ...

  • Industries : Biopharmaceutical
  • Countries : United States
Freedonia Focus on Biocompatible Materials: United States

Freedonia Focus on Biocompatible Materials: United States

  • $ 600
  • Industry report
  • December 2014
  • by Freedonia Focus

This report forecasts US biocompatible materials demand in US dollars at the manufacturers' level to 2018. Total demand is segmented by product in terms of synthetic polymers, natural polymers, ceramics, ...

  • Industries : Biomaterial
  • Countries : United States
Freedonia Focus on Biocompatible Metals: United States

Freedonia Focus on Biocompatible Metals: United States

  • $ 600
  • Industry report
  • December 2014
  • by Freedonia Focus

This report forecasts US biocompatible metal demand in US dollars at the manufacturers' level to 2018. Total demand is segmented by material in terms of precious metals, stainless steel, titanium, and ...

  • Industries : Biomaterial
  • Countries : United States
Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Taiwan, Japan
Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Canada
Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Health Discovery Corporation (Symbol:HDVY) SWOT Analysis, Strategy, Revenues and Profits

Health Discovery Corporation (Symbol:HDVY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States, Georgia
Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
NanoCarrier Co., Ltd. (Symbol:4571) SWOT Analysis, Strategy, Revenues and Profits

NanoCarrier Co., Ltd. (Symbol:4571) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology, Nanotechnology
  • Countries : Japan, United States
Nanosphere, Inc. (Symbol:NSPH) SWOT Analysis, Strategy, Revenues and Profits

Nanosphere, Inc. (Symbol:NSPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Nanotechnology, Biotechnology
  • Countries : United States
PharmAthene, Inc. (Symbol:PIP) SWOT Analysis, Strategy, Revenues and Profits

PharmAthene, Inc. (Symbol:PIP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Protalex, Inc. (Symbol:PRTX) SWOT Analysis, Strategy, Revenues and Profits

Protalex, Inc. (Symbol:PRTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, South Africa
Response Genetics, Inc. (Symbol:RGDX) SWOT Analysis, Strategy, Revenues and Profits

Response Genetics, Inc. (Symbol:RGDX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
Transgene SA (Symbol:TNG) SWOT Analysis, Strategy, Revenues and Profits

Transgene SA (Symbol:TNG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : France, United States
iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary iBio, Inc. (iBio) is a biotechnology company. The company develops and offers pharmaceutical product applications. It offers products such as vaccines, and biotherapeutics. iBio offers vaccines ...

  • Industries : Biopharmaceutical
  • Countries : United States
Shin Nippon Biomedical Laboratories, Ltd. (Symbol:2395) SWOT Analysis, Strategy, Revenues and Profits

Shin Nippon Biomedical Laboratories, Ltd. (Symbol:2395) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Iris BioTechnologies Inc. (Symbol:IRSB) SWOT Analysis, Strategy, Revenues and Profits

Iris BioTechnologies Inc. (Symbol:IRSB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States

10 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.